OREX
Knobias Clip Report (10-17-2007)
Thursday, October 18th, 2007Rating 3.00 out of 5
[?]Sumbmited From Knobias ClipReport
OREX: Shares Up on Initiation of Ph III Trial for Contrave(TM) Obesity Drug
Shares of Orexigen Therapeutics, Inc. (OREX) opened higher in Wednesday’s session with the initiation of the third trial in its Phase III clinical trial program for its lead product candidate Contrave(TM) as a treatment for obesity. […]
